Marpai, Inc. (MRAI) Research
Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel. The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures. Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
Market snapshot
- Symbol
- MRAI
- Price
- $0.66
- Day change
- +6.29%
- Market cap
- $13.1M
- P/E ratio
- -0.98x
- 52-week range
- 0.215-1.78
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Next earnings
- in 2 months
- Analyst price target
- $6.00
Peer companies
Recent insider activity
- EITAN YARON — D-Return (50000 shares) on 2025-12-08
- EITAN YARON — A-Award (175000 shares) on 2026-05-29
- Johnson Steve Andrew — A-Award (125000 shares) on 2026-05-29
- Johnson Steve Andrew — P-Purchase (1100 shares) on 2026-06-02
- SHIV SAGIV — D-Return (50000 shares) on 2025-12-08
Open Marpai, Inc. (MRAI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.